218 related articles for article (PubMed ID: 17463088)
1. GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model.
Kamnasaran D; Qian B; Hawkins C; Stanford WL; Guha A
Proc Natl Acad Sci U S A; 2007 May; 104(19):8053-8. PubMed ID: 17463088
[TBL] [Abstract][Full Text] [Related]
2. Trapping the mouse genome to hunt human alterations.
Bleau AM; Holland EC
Proc Natl Acad Sci U S A; 2007 May; 104(19):7737-8. PubMed ID: 17483476
[No Abstract] [Full Text] [Related]
3. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
4. Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.
Shannon P; Sabha N; Lau N; Kamnasaran D; Gutmann DH; Guha A
Am J Pathol; 2005 Sep; 167(3):859-67. PubMed ID: 16127163
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
6. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
8. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
9. Mouse glioma gene expression profiling identifies novel human glioma-associated genes.
Gutmann DH; Huang ZY; Hedrick NM; Ding H; Guha A; Watson MA
Ann Neurol; 2002 Mar; 51(3):393-405. PubMed ID: 11891838
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.
Bögler O; Nagane M; Gillis J; Huang HJ; Cavenee WK
Cell Growth Differ; 1999 Feb; 10(2):73-86. PubMed ID: 10074901
[TBL] [Abstract][Full Text] [Related]
11. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
12. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
13. Characterization and transformation potential of "Synthetic" astrocytes differentiated from murine embryonic stem cells.
Kamnasaran D; Hawkins C; Guha A
Glia; 2008 Mar; 56(4):457-70. PubMed ID: 18205175
[TBL] [Abstract][Full Text] [Related]
14. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes.
Johnson WB; Ruppe MD; Rockenstein EM; Price J; Sarthy VP; Verderber LC; Mucke L
Glia; 1995 Mar; 13(3):174-84. PubMed ID: 7782103
[TBL] [Abstract][Full Text] [Related]
15. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
Marsh J; Mukherjee P; Seyfried TN
Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
[TBL] [Abstract][Full Text] [Related]
16. Expression of GATA6 in the human and mouse central nervous system.
Kamnasaran D; Guha A
Brain Res Dev Brain Res; 2005 Nov; 160(1):90-5. PubMed ID: 16150495
[TBL] [Abstract][Full Text] [Related]
17. ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties.
Hubstenberger A; Labourdette G; Baudier J; Rousseau D
Exp Cell Res; 2008 Sep; 314(15):2870-83. PubMed ID: 18639545
[TBL] [Abstract][Full Text] [Related]
18. NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.
Moreira F; Kiehl TR; So K; Ajeawung NF; Honculada C; Gould P; Pieper RO; Kamnasaran D
Am J Pathol; 2011 Jul; 179(1):462-76. PubMed ID: 21703424
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.
Bajenaru ML; Zhu Y; Hedrick NM; Donahoe J; Parada LF; Gutmann DH
Mol Cell Biol; 2002 Jul; 22(14):5100-13. PubMed ID: 12077339
[TBL] [Abstract][Full Text] [Related]
20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
